Skip to content

Asset turnover at other companies

Opko Health logo
Opko HealthOPK
0.3×0.0×
AMP
Amphastar PharmaceuticalsAMPH
0.4×0.0×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
0.5×+0.3×
Theravance Biopharma logo
Theravance BiopharmaTBPH
0.3×+0.1×
HRO
HarrowHROW
0.7×0.0×
Precigen logo
PrecigenPGEN

Other financials

Income statement

See full
Revenue$58.3M+104%
Gross profit$46.3M+86.8%
Operating income-$15.5M+80.4%
Net income-$30.4M+67.8%
EPS (diluted)-$0.37+71.8%

Balance sheet

See full
Cash & equivalents$180.9M-14.8%
Total debt$166.3M-18.3%
Total equity-$337.0M+0.4%
Total assets$305.1M+3.7%

Cash flow

See full
Operating cash flow-$15.6M+81.6%
CapEx$61.0K+239%
Free cash flow-$15.7M+81.5%

Valuation

See full
Market cap$846.21M+16.3%
Enterprise value$831.61M+15.7%
P/S4.1×-4.8×

Profitability

See full
Gross margin84.9%-1.3pp
Operating margin-47.1%-21.9pp
Net margin-76.8%-34.5pp
FCF margin-47.7%-22.1pp

Returns & leverage

See full
Return on equity-147.9%
Debt / equity5.6×
Current ratio2.2×-1.4×

Where this comes from

Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phathom Pharmaceuticals, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phathom Pharmaceuticals, Inc.'s asset turnover?
Phathom Pharmaceuticals, Inc. (PHAT) reported asset turnover of 0.7× in Q1 2026.
How has Phathom Pharmaceuticals, Inc.'s asset turnover changed year-over-year?
Phathom Pharmaceuticals, Inc.'s asset turnover increased by 171.7% year-over-year, from 0.3× to 0.7×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.